Top

10-05-2016 | Multiple myeloma | Article

MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings

Journal: Insights into Imaging

Authors: Julie C. Dutoit, Koenraad L. Verstraete

Publisher: Springer Berlin Heidelberg

Abstract

Magnetic resonance imaging (MRI) is increasingly being used in the diagnostic work-up of patients with multiple myeloma. Since 2014, MRI findings are included in the new diagnostic criteria proposed by the International Myeloma Working Group. Patients with smouldering myeloma presenting with more than one unequivocal focal lesion in the bone marrow on MRI are considered having symptomatic myeloma requiring treatment, regardless of the presence of lytic bone lesions. However, bone marrow evaluation with MRI offers more than only morphological information regarding the detection of focal lesions in patients with MM. The overall performance of MRI is enhanced by applying dynamic contrast-enhanced MRI and diffusion weighted imaging sequences, providing additional functional information on bone marrow vascularization and cellularity.

This pictorial review provides an overview of the most important imaging findings in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma, by performing a ‘total’ MRI investigation with implications for the diagnosis, staging and response assessment.

Main message

• Conventional MRI diagnoses multiple myeloma by assessing the infiltration pattern.

• Dynamic contrast-enhanced MRI diagnoses multiple myeloma by assessing vascularization and perfusion.

• Diffusion weighted imaging evaluates bone marrow composition and cellularity in multiple myeloma.

• Combined morphological and functional MRI provides optimal bone marrow assessment for staging.

• Combined morphological and functional MRI is of considerable value in treatment follow-up.

Nanni C, Rubello D, Fanti S et al (2006) Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer. Biomed Pharmacother 60:409–413CrossRefPubMed

Kyle RA, Durie BG, Rajkumar SV et al (2010) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24:1121–1127CrossRefPubMed

Smith D, Yong K (2013) Multiple myeloma. BMJ 346:f3863CrossRefPubMed

Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538–548CrossRefPubMed

Rajkumar SV (2016) Myeloma today: disease definitions and treatment advances. Am J Hematol 91:90–100CrossRefPubMed

Pratt G, Bowcock S, Chantry A et al (2015) Time to redefine myeloma. Br J Haematol 171:1–10CrossRefPubMed

Dimopoulos MA, Hillengass J, Usmani S et al (2015) Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol 33:657–664CrossRefPubMed

Hillengass J, Landgren O (2013) Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging “early myeloma”. Leuk Lymphoma 54:1355–1363CrossRefPubMed

Hillengass J, Fechtner K, Weber MA et al (2010) Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 28:1606–1610CrossRefPubMed

10.

Padhani AR, Khan AA (2010) Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy. Target Oncol 5:39–52CrossRefPubMed

11.

Caers J, Withofs N, Hillengass J et al (2014) The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma. Haematologica 99:629–637CrossRefPubMedPubMedCentral

12.

Derlin T, Weber C, Habermann CR et al (2012) 18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation. Eur J Nucl Med Mol Imaging 39:493–500CrossRefPubMed

13.

Silva JR Jr, Hayashi D, Yonenaga T et al (2013) MRI of bone marrow abnormalities in hematological malignancies. Diagn Interv Radiol 19:393–399PubMed

14.

Vande Berg BC, Malghem J, Lecouvet FE, Maldague B (1998) Magnetic resonance imaging of the normal bone marrow. Skelet Radiol 27:471–483CrossRef

15.

Shah LM, Hanrahan CJ (2011) MRI of spinal bone marrow: part I, techniques and normal age-related appearances. AJR Am J Roentgenol 197:1298–1308CrossRefPubMed

16.

Dutoit JC, Vanderkerken MA, Anthonissen J, Dochy F, Verstraete KL (2014) The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma. Eur Radiol 24:2754–2765CrossRefPubMed

17.

Mena E, Choyke P, Tan E, Landgren O, Kurdziel K (2011) Molecular imaging in myeloma precursor disease. Semin Hematol 48:22–31CrossRefPubMedPubMedCentral

18.

Turkbey B, Thomasson D, Pang Y, Bernardo M, Choyke PL (2010) The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol 16:186–192PubMed

19.

Verstraete KL, Van der Woude HJ, Hogendoorn PC, De-Deene Y, Kunnen M, Bloem JL (1996) Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging 6:311–321CrossRefPubMed

20.

Dutoit JC, Vanderkerken MA, Verstraete KL (2013) Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. Eur J Radiol 82:1444–1452CrossRefPubMed

21.

Verstraete KL, Vanzieleghem B, De Deene Y et al (1995) Static, dynamic and first-pass MR imaging of musculoskeletal lesions using gadodiamide injection. Acta Radiol 36:27–36CrossRefPubMed

22.

Lavini C, de Jonge MC, van de Sande MG, Tak PP, Nederveen AJ, Maas M (2007) Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system. Magn Reson Imaging 25:604–612CrossRefPubMed

23.

Padhani AR, Leach MO (2005) Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging. Abdom Imaging 30:324–341CrossRefPubMed

24.

Garcia-Figueiras R, Padhani AR, Beer AJ et al (2015) Imaging of tumor angiogenesis for radiologists--part 1: biological and technical basis. Curr Probl Diagn Radiol 44:407–424CrossRefPubMed

25.

Hayes C, Padhani AR, Leach MO (2002) Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 15:154–163CrossRefPubMed

26.

Padhani AR, van Ree K, Collins DJ, D’Sa S, Makris A (2013) Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI. AJR Am J Roentgenol 200:163–170CrossRefPubMed

27.

Khoo MM, Tyler PA, Saifuddin A, Padhani AR (2011) Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review. Skeleta Radiol 40:665–681CrossRef

28.

Bannas P, Hentschel HB, Bley TA et al (2012) Diagnostic performance of whole-body MRI for the detection of persistent or relapsing disease in multiple myeloma after stem cell transplantation. Eur Radiol 22:2007–2012CrossRefPubMed

29.

Padhani AR, Koh DM, Collins DJ (2011) Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 261:700–718CrossRefPubMed

30.

Messiou C, Giles S, Collins DJ et al (2012) Assessing response of myeloma bone disease with diffusion-weighted MRI. Br J Radiol 85:e1198–1203CrossRefPubMedPubMedCentral

31.

Merz M, Hielscher T, Wagner B et al (2014) Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma. Leukemia 28:1902–1908CrossRefPubMed

32.

Hillengass J, Zechmann C, Bauerle T et al (2009) Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation. Clin Cancer Res 15:3118–3125CrossRefPubMed

33.

Schmidt GP, Reiser MF, Baur-Melnyk A (2007) Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skelet Radiol 36:1109–1119CrossRef

34.

Alyas F, Saifuddin A, Connell D (2007) MR imaging evaluation of the bone marrow and marrow infiltrative disorders of the lumbar spine. Magn Reson Imaging Clin N Am 15(199–219):vi

35.

Baur-Melnyk A, Buhmann S, Durr HR, Reiser M (2005) Role of MRI for the diagnosis and prognosis of multiple myeloma. Eur J Radiol 55:56–63CrossRefPubMed

36.

Stabler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF (1996) Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. AJR Am J Roentgenol 167:1029–1036CrossRefPubMed

37.

Jakob C, Sterz J, Zavrski I et al (2006) Angiogenesis in multiple myeloma. Eur J Cancer 42:1581–1590CrossRefPubMed

38.

Baur A, Bartl R, Pellengahr C, Baltin V, Reiser M (2004) Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histopathologic findings. Cancer 101:2599–2604CrossRefPubMed

39.

Moehler TM, Hawighorst H, Neben K et al (2001) Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging. Int J Cancer 93:862–868CrossRefPubMed

40.

Zha Y, Li M, Yang J (2010) Dynamic contrast enhanced magnetic resonance imaging of diffuse spinal bone marrow infiltration in patients with hematological malignancies. Korean J Radiol 11:187–194CrossRefPubMedPubMedCentral

41.

Nosas-Garcia S, Moehler T, Wasser K et al (2005) Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers. J Magn Reson Imaging 22:154–162CrossRefPubMed

42.

Lecouvet FE, Larbi A, Pasoglou V et al (2013) MRI for response assessment in metastatic bone disease. Eur Radiol 23:1986–1997CrossRefPubMed

43.

Daldrup-Link HE, Henning T, Link TM (2007) MR imaging of therapy-induced changes of bone marrow. Eur Radiol 17:743–761CrossRefPubMed

44.

Moulopoulos LA, Koutoulidis V (2015) Bone marrow MRI, a pattern-based approach. Springer, Milan

45.

Fenchel M, Konaktchieva M, Weisel K et al (2010) Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results. Eur Radiol 20:2899–2906CrossRefPubMed

46.

Horger M, Weisel K, Horger W, Mroue A, Fenchel M, Lichy M (2011) Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results. AJR Am J Roentgenol 196:W790–795CrossRefPubMed

47.

Giles SL, Messiou C, Collins DJ et al (2014) Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma. Radiology 271:785–794CrossRefPubMed

48.

Lin C, Luciani A, Belhadj K et al (2010) Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging. Radiology 254:521–531CrossRefPubMed

49.

Zechmann CM, Traine L, Meissner T et al (2012) Parametric histogram analysis of dynamic contrast-enhanced MRI in multiple myeloma: a technique to evaluate angiogenic response to therapy? Acad Radiol 19:100–108CrossRefPubMed

50.

Dutoit JC, Claus E, Offner F, Noens L, Delanghe J, Verstraete KL (2016) Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma. Eur J Radiol 85:373–382CrossRefPubMed

51.

Koh DM (2010) Qualitative and quantitative analyses: image evaluation and interpretation. In: Koh DMTH (ed) Diffusion-weighted MR imaging applications in the body. Springer, Heidelberg, pp 33–47CrossRef

52.

Derlin T, Bannas P (2014) Imaging of multiple myeloma: current concepts. World J Orthod 5:272–282CrossRef

Medicine Matters Oncology

Abstract